Brief: Unicycive Therapeutics Granted New U.S. Patent For Uni-494 To Treat Chronic Kidney Disease
18/08/2025 14:55
Aug 18 (Reuters) - Unicycive Therapeutics Inc UNCY.O: UNICYCIVE THERAPEUTICS GRANTED NEW U.S. PATENT FOR UNI-494 TO TREAT CHRONIC KIDNEY DISEASE Source text: ID:nGNXbXyB7j Further company coverage: UNCY.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss